Highly efficient selection of tumor neoantigens improves therapeutic cancer vaccine efficacy by Annie De Groot | Nov 12, 2019 | 0 comments Highly efficient selection of tumor neoantigens improves therapeutic cancer vaccine efficacy Submit a CommentYou must be logged in to post a comment.
